[Treatment of hepatitis C virus infection with new direct-acting antivirals agents in pediatrics. Case report].

doi:10.5546/aap.2021.e360

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

[Treatment of hepatitis C virus infection with new direct-acting antivirals agents in pediatrics. Case report].

Archivos argentinos de pediatria - 1 Aug 2021

Selzer Soria Erika M, Malla Ivone

Abstract excerpt

Hepatitis C virus infection in children occurs mainly through vertical transmission. The natural history at this age consists in a high rate of spontaneous clearance, asymptomatic infection, or minimal histological changes. Disease complications are commonly seen in adolescence or adulthood. The classic treatment with pegylated interferon and ribavirin presents adverse effects, prolonged duration and achieves...

Topics

Adolescent
Adult
Antiviral Agents
Child
Drug Therapy, Combination
Genotype
Hepacivirus
Hepatitis C, Chronic
Humans
Pediatrics
Sofosbuvir
Treatment Outcome

Source

Open in PubMed

Identifiers

PMID: 34309319
DOI: 10.5546/aap.2021.e360

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics